Medicine Man Technologies, Inc. (OTCQX:MDCL)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

Medicine Man Technologies, Inc. announces launch of direct operator division of licensed cannabis operations

DENVER – January 17, 2019 – Today Medicine Man Technologies (OTCQX: MDCL), a leading consulting, intellectual property licensing and products company in the cannabis industry, has announced a binding agreement that is expected to lead to the near-term acquisition of the Colorado licensee, Medicine Man Denver (MMD). MMD is one of the pioneering operators that helped establish the burgeoning cannabis industry over the past decade, with brand recognition far beyond its immediate market.  Its operations include one of the largest indoor cultivations in the state of Colorado as well as four retail locations with combined sales that have kept it in the top tier of operators in the state.

 

MDCL plans to pursue other acquisitions and partnerships with similar, mature industry leading operators, in the birth place of the legal cannabis industry and beyond

 

These planned and prospective transactions are helping to realize the promise of MDCL’s vision to establish an industry-leading, fully-integrated cannabis company that delivers resources to entrepreneurs in the industry and soon, products to consumers.

 

“Building upon MMT’s established expertise as consultants that have helped win licenses and establish operations in 17 states with over 100 clients, these moves are keeping the promise of Medicine Man Technologies’ vision to become an operator in this space,” says Andy Williams, Medicine Man Technologies’ Chief Executive Officer.  “Once officially brought into the fold, MDCL’s annual revenue run rate will exceed $40 million.  We couldn’t be more excited about what the future holds.”

 

Because MMD is a holder of cannabis licenses issued by the Marijuana Enforcement Division (MED) in the State of Colorado, the acquisition of MMD will require the passing of the currently-introduced Colorado HB19-1090 (https://leg.colorado.gov/bills/hb19-1090) which is currently working its way through the legislature, with support of the current governor.  If HB19-1090 becomes law, it will allow for public company ownership of Colorado-licensed cannabis businesses.

 

The final acquisition will require the approval of the MED, as well as local city and county rules concerning the transfer and sale of ownership interest.  Due to current legal restrictions, rather than acquiring a direct right to purchase the entity, MDCL has agreed to license MMD’s company brand globally and issue warrants that can only be exercised by the exchange of equity of MMD for common stock of MDCL at an agreed upon value subject to approval by the MED and the warrant holders electing to exercise.

 

MDCL had previously disclosed in its SEC filings of its intent to acquire MMD, as several persons connected to MDCL are also owners of MMD, including Andy Williams, current CEO of MDCL. MDCL has obtained indepedent valuations of the entities to be acquired. The relevant term sheet provides that the value of the shares to be issued to each owner of the entities to be acquired shall be consistent with these independent valuations.

 

About Medicine Man Technologies, Inc.

Established in March 2014, the Company secured its first client/licensee in April 2014. To date, the Company has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. The Company currently has or has had active clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Oklahoma, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa. The Company continues to focus on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company’s highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will “share” the ever-improving experience and knowledge of the network, and 5) continuing the expansion of our Brands Warehouse concept through entry into industry based cooperative agreements and pursuing other acquisitions as they prove suitable to our overall business development strategy.

 

Safe Harbor Statement

This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based on many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company’s most recent SEC filings. We have incurred and will continue to incur significant expenses in the expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long-term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.

 

Source:  Medicine Man Technologies

MEDICINE MAN TECHNOLOGIES Enters into Agreement to Acquire MedPharm Holdings, LLC

Medicine Man Technologies Adds Marijuana Research Company, Branded Product Lines and Intellectual Property Development Capabilities to Their International Base of Over 100 Clients

 

DENVER, CO /  January 15, 2019 / Medicine Man Technologies (OTCQX: MDCL), a leading consulting, IP licensing and products company in the cannabis industry, has signed binding term sheets and conditions for acquisition of MedPharm Holdings, LLC, an intellectual property development and holding company focused on cannabis research and product/brand development.

 

MedPharm Holdings, LLC provides extraction expertise, cannabis pharmaceutical-grade dosage forms using current “Good Manufacturing Practices” that include pre-formulation; formulation development; commercial manufacturing; analytical method development and validation; and routine quality control analysis and stability studies. MedPharm’s capabilities also allow for in-depth analysis to include clinical studies. MedPharm’s popular brands include: Aliviar, a medically focused line with a proprietary blend of cannabinoids, terpenes, niosomes, essential oils and other excipients; become, a pure cannabis concentrate marketed to the female demographic and BATCH, high-quality extracts for the connoisseur.

 

MedPharm Holdings, LLC has two licensees. The first is MX, LLC in Colorado, an extraction and marijuana-infused products company, which holds the only Colorado state cannabis research license. The second is MedPharm Iowa, a vertically integrated medical marijuana company. MedPharm Holdings, LLC also has a pending application for a federal research Bulk Manufacturer license to provide cannabis and cannabis dosage forms for research purposes.

 

MedPharm Holdings, LLC is currently solidifying an international expansion in South America and evaluating opportunities in other continents.

 

”This planned acquisition of MedPharm Holdings, LLC brings world-class processing, research and pharmaceutical-grade products to the Medicine Man Technologies’ portfolio. This is a significant step in becoming a dominant global operator, filling a key gap in our current products and services,” says Andy Williams, Medicine Man Technologies’ Chief Executive Officer. ”We have had clients in 17 states and seven countries, this highly scalable product line allows us to leverage those existing relationships worldwide.”

 

The acquisition of MedPharm Holdings, LLC is expected to close sometime in the first quarter of 2019 pending completion of due diligence.

 

About Medicine Man Technologies, Inc.

Established in March 2014, the Company secured its first client/licensee in April 2014. To date, the Company has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. The Company currently has or has had active clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Oklahoma, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa. The Company continues to focus on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company’s highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will “share” the ever-improving experience and knowledge of the network, and 5) continuing the expansion of our Brands Warehouse concept through entry into industry based cooperative agreements and pursuing other acquisitions as they prove suitable to our overall business development strategy.

 

Safe Harbor Statement

This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based on many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company’s most recent SEC filings. We have incurred and will continue to incur significant expenses in the expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long-term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.

 

Contact Information:

Brett Roper via
info@medicinemantechnologies.com
Telephone (303) 371-0387

SOURCE: Medicine Man Technologies

About Medicine Man Technologies

A BRIEF HISTORY OF MEDICINE MAN TECHNOLOGIES

 

In late 2012, Andy Williams was introduced to Brett Roper and subsequent discussions revealed the substantial value of creating a new company that could “house” as well as deliver the substantial experience Medicine Man Denver had acquired over the past five years. In April 2014, the business venture incorporated in Nevada as a ‘C’ Corporation under the name of Medicine Man Technologies, Inc. and began generating revenues through sales of consulting and licensing services. Since the business is based in the advisory and consulting space and not in the actual growing and distribution of the product, the company completed it’s public company filing and had it’s first public sale in January 2016.

 

Medicine Man Technologies offers cannabis consulting, licensing our state-of-the-art cultivation and dispensary operating solutions. We provide the experience and expertise to clients who have the resources necessary to enter the competitive medical and recreational cannabis marketplace.

 

Consulting Services

 

Through our pre-licensure consulting services, Medicine Man Technologies will support your efforts within a competitive or non-competitive state application process with the goal of helping your team secure a state-issued operating license. Our proven operational experience and state-of-the-art technology has successfully distinguished our clients in this emerging industry.

 

Cultivation Technology

 

Our risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. Through our licensure services we provide standard operating procedures for all phases of commercial and industrial cannabis cultivation, from clone to counter. In addition, we provide hands-on training and development for your personnel both at Medicine Man Denver and your facility once operational.

 

Dispensary Operations

 

Our state-of-the art dispensary model ensures patients and consumers have safe and secure access to a variety of medical and/or recreational cannabis products. Through our licensure services we provide standard operating procedures for dispensary facilities, as well as staffing plans, job descriptions and hands-on training for dispensary personnel both at Medicine Man Denver and your facility once operational.

 

Preferred Partners

 

We work closely with industry-leading extraction partners, who provide the necessary licensing service support and formulations to assist clients with their planned deployment of a successful processing facility. This includes; Dixie Elixirs, Medically Correct, CanCore Concepts, and Tree Frog.

 

Get Started

 

Operating in this emerging industry requires experienced partners who can help you avoid costly mistakes. Medicine Man Technologies’ team of professional consultants can help you navigate the process of becoming a successful cannabis operation. If you’re interested in learning more, we would love to hear from you.

 

TEAM BIOGRAPHIES

 

Andy Williams – Chairman of the Board

Andy Williams is the Co-Founder and Chairman of the Board of Medicine Man Technologies and CEO of Medicine Man in Colorado. He is veteran of the US Army, and served three years as a Cavalry Scout in the 3rd Infantry Division. He went on to earn a Bachelor of Science degree in Industrial Engineering from the University of Southern Colorado in Pueblo, CO. Andy has worked in a wide range of manufacturing industries as an industrial engineer, and in leadership positions. He is a lifelong entrepreneur. In 2009 the Ogden letter was published stating the Department of Justice would not utilize their resources to prosecute those individuals following state marijuana laws. That was the call to a new opportunity in the marijuana industry for Andy and his brother, Pete Williams. In December of 2009 they launched Medicine Man with the concept of being the Costco of marijuana. Six years later Medicine Man is now a $17 million a year corporation and has branched out to assist start up marijuana companies and grow facilities across the country with their consulting company, Medicine Man Technologies. They are known as industry leaders throughout the United States.

 

 

Brett Roper – CEO & Co-Founder

Mr. Roper has an extensive background in business development, having successfully ‘shepherded’ several Form 10 and S1 filings as well as NASDAQ up listing efforts, most recently co-founding Medicine Man Technologies, a unique cannabis business consultant and advisory service provider. Mr. Roper has a substantial amount of RE based experience, managing acquisition, interim holding, and disposition of substantial industrial properties in the 50,000 to 400,000 SF range and is active in providing design insights for cannabis related property deployment. Mr. Roper has been responsible for management of a national marketing program for a regional RE developer having relationships with SIOR, NAI, CORFAC Global, NAIOP, and other real estate organizations across the country. Mr. Roper has served in a number of advisory capacities to other pre-public and public companies including corporate development, strategic initiative refinement, business turnaround, service as an independent board member, and management of investor relations fundamentals. His extraordinary background has allowed him to become a well-rounded ‘quiet advisor’ to many companies as well as investors in the Canna-business space.

 

 

Marc Harvill – Sr. Consultant

As a Sr. Consultant, Marc is responsible for following emerging markets, managing new and existing client relationships, and coordinating training efforts for licensees of Medicine Man Technologies. Marc has a background in pharmacy operations both in the manufacturing and retail space, with more than 10 years of experience. He holds a B.A in Marketing and Spanish from PSU and an M.B.A from Washburn University. Prior to joining Medicine Man Technologies, Marc worked for one of the largest privately operated pharmacy technology companies in the country, specifically focused on training and development, hardware and software testing and quality assurance.

 

 

Matt Best – Sr. Consultant

As Sr. Consultant, Matt is responsible for following emerging markets, managing new and existing client relationships, and marketing and event management for the company. He holds a B.A. in Communication and Integrated Marketing Communications from the State University of New York, College at Geneseo. Prior to joining MMT in 2015, Matt worked in the Media department at a prominent national advertising agency while overseeing the media planning and buying team and maintaining responsibility for client relationships across local, regional, and national media accounts. He has a strong background in organizational and interpersonal communication, project management, as well as expertise in marketing, business development and client relations. Matt is an avid skier and enjoys time spent within the National Parks.

 

 

Carrie Roberts – Sr. Consultant

Carrie Roberts is a Senior Consultant with Medicine Man Technologies. She has a BA in Sociology and Criminal Justice from Colorado State University. As a former Colorado POST Certified law enforcement officer Carrie is currently on the speakers’ bureau for LEAP (Law Enforcement Action Partnership), an international, non-profit, criminal justice reform agency speaking to both policy makers and the public regarding criminal justice and drug policy reform measures. In this capacity, she is able to provide cultivation and dispensary facility tours, educational presentations and actionable intelligence for law enforcement and legislative officials in states where marijuana legalization is unfolding. She helps those government officials understand how legalizing, taxing and regulating marijuana increases public safety, improves the criminal justice system, enhances racial justice, protects young people, safeguards patients, saves resources, bolsters public health, and generates revenue. Carrie is also on the standards creation board for FOCUS (Foundation of Cannabis Unified Standards), an independent, non-profit, third party source for the creation of cannabis standards. In addition to her law enforcement experience, she has over 13 years of entrepreneurial business experience. As a private investigator, she began the nation’s first mystery shopping company focused exclusively on the cannabis industry to help dispensary operators focus on maintaining compliance, setting standards, and delivering superior customer experience. She has a strong business background in strategic consulting and strategy development, as well as expertise in marketing, business development, and customer experience management.

 

Source:  https://www.medicinemantechnologies.com/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for Medicine Man Technologies, Inc. current news coverage by the company.  FNMG HOLDS NO SHARES OF Medicine Man Technologies, Inc.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Sign Up & Get FREE News Alerts From FNM Today!